279 related articles for article (PubMed ID: 22382838)
1. [Safety assessment of nanomaterials in reproductive developmental field].
Yamashita K; Yoshioka Y
Yakugaku Zasshi; 2012; 132(3):331-5. PubMed ID: 22382838
[TBL] [Abstract][Full Text] [Related]
2. [Safety assessment of nanomaterials for development of nano-cosmetics].
Yoshida T; Yoshioka Y; Tsutsumi Y
Yakugaku Zasshi; 2012; 132(11):1231-6. PubMed ID: 23123712
[TBL] [Abstract][Full Text] [Related]
3. [Nanosafety studies of nanomaterials about biodistribution and immunotoxicity].
Yoshioka Y
Yakugaku Zasshi; 2011 Feb; 131(2):221-4. PubMed ID: 21297365
[TBL] [Abstract][Full Text] [Related]
4. [Biodistribution of nanosilica particles in pregnant mice and the potential risk on the reproductive development].
Nagano K
Yakugaku Zasshi; 2011 Feb; 131(2):225-8. PubMed ID: 21297366
[TBL] [Abstract][Full Text] [Related]
5. [Nano-safety science for assuring the safety of nanomaterials].
Yoshioka Y; Yoshikawa T; Tsutsumi Y
Nihon Eiseigaku Zasshi; 2010 Sep; 65(4):487-92. PubMed ID: 20885074
[TBL] [Abstract][Full Text] [Related]
6. Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes.
Tavares AM; Louro H; Antunes S; Quarré S; Simar S; De Temmerman PJ; Verleysen E; Mast J; Jensen KA; Norppa H; Nesslany F; Silva MJ
Toxicol In Vitro; 2014 Feb; 28(1):60-9. PubMed ID: 23811260
[TBL] [Abstract][Full Text] [Related]
7. [Safety studies of nanomaterials about intracellular distribution and genotoxicity].
Abe Y
Yakugaku Zasshi; 2011 Feb; 131(2):215-9. PubMed ID: 21297364
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Skin Permeability and Toxicological Properties of Amorphous Silica Particles.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Biol Pharm Bull; 2016; 39(7):1201-5. PubMed ID: 27374294
[TBL] [Abstract][Full Text] [Related]
9. Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application.
Nabeshi H; Yoshikawa T; Matsuyama K; Nakazato Y; Matsuo K; Arimori A; Isobe M; Tochigi S; Kondoh S; Hirai T; Akase T; Yamashita T; Yamashita K; Yoshida T; Nagano K; Abe Y; Yoshioka Y; Kamada H; Imazawa T; Itoh N; Nakagawa S; Mayumi T; Tsunoda S; Tsutsumi Y
Biomaterials; 2011 Apr; 32(11):2713-24. PubMed ID: 21262533
[TBL] [Abstract][Full Text] [Related]
10. [Relation analysis between intracellular distribution of nanomateriarls, ROS generation and DNA damage].
Yoshida T; Yoshikawa T; Nabeshi H; Tsutsumi Y
Yakugaku Zasshi; 2012; 132(3):295-300. PubMed ID: 22382833
[TBL] [Abstract][Full Text] [Related]
11. Relevance of Physicochemical Characterization of Nanomaterials for Understanding Nano-cellular Interactions.
Louro H
Adv Exp Med Biol; 2018; 1048():123-142. PubMed ID: 29453536
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the toxicity of selected types of nanochemicals.
Kumar V; Kumari A; Guleria P; Yadav SK
Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
[TBL] [Abstract][Full Text] [Related]
13. Nanotoxicity: a growing need for study in the endocrine system.
Lu X; Liu Y; Kong X; Lobie PE; Chen C; Zhu T
Small; 2013 May; 9(9-10):1654-71. PubMed ID: 23401134
[TBL] [Abstract][Full Text] [Related]
14. [Recent topics about nano-safety science and its future].
Yoshioka Y; Yoshikawa T; Nabeshi H; Tsutsumi Y
Yakugaku Zasshi; 2013; 133(2):169-74. PubMed ID: 23370508
[TBL] [Abstract][Full Text] [Related]
15. [Transdermal penetration and biodistribution of nanomaterials and their acute toxicity in vivo].
Tsunoda S
Yakugaku Zasshi; 2011 Feb; 131(2):203-7. PubMed ID: 21297362
[TBL] [Abstract][Full Text] [Related]
16. Risk management strategy to increase the safety of workers in the nanomaterials industry.
Ling MP; Lin WC; Liu CC; Huang YS; Chueh MJ; Shih TS
J Hazard Mater; 2012 Aug; 229-230():83-93. PubMed ID: 22727485
[TBL] [Abstract][Full Text] [Related]
17. Environmental and health effects of nanomaterials in nanotextiles and façade coatings.
Som C; Wick P; Krug H; Nowack B
Environ Int; 2011 Aug; 37(6):1131-42. PubMed ID: 21397331
[TBL] [Abstract][Full Text] [Related]
18. Morphological observation of embryoid bodies completes the in vitro evaluation of nanomaterial embryotoxicity in the embryonic stem cell test (EST).
Corradi S; Dakou E; Yadav A; Thomassen LC; Kirsch-Volders M; Leyns L
Toxicol In Vitro; 2015 Oct; 29(7):1587-96. PubMed ID: 26093180
[TBL] [Abstract][Full Text] [Related]
19. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice.
Yamashita K; Yoshioka Y; Higashisaka K; Mimura K; Morishita Y; Nozaki M; Yoshida T; Ogura T; Nabeshi H; Nagano K; Abe Y; Kamada H; Monobe Y; Imazawa T; Aoshima H; Shishido K; Kawai Y; Mayumi T; Tsunoda S; Itoh N; Yoshikawa T; Yanagihara I; Saito S; Tsutsumi Y
Nat Nanotechnol; 2011 May; 6(5):321-8. PubMed ID: 21460826
[TBL] [Abstract][Full Text] [Related]
20. Serum enhanced cytokine responses of macrophages to silica and iron oxide particles and nanomaterials: a comparison of serum to lung lining fluid and albumin dispersions.
Brown DM; Johnston H; Gubbins E; Stone V
J Appl Toxicol; 2014 Nov; 34(11):1177-87. PubMed ID: 24737200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
